S&P 500   3,959.56 (-0.10%)
DOW   33,683.61 (-0.29%)
QQQ   283.68 (-0.06%)
AAPL   143.94 (+0.90%)
MSFT   246.44 (-0.39%)
META   116.46 (+0.98%)
GOOGL   93.29 (-0.45%)
AMZN   89.57 (-0.86%)
TSLA   180.30 (+3.96%)
NVDA   172.75 (+0.62%)
NIO   12.81 (-4.47%)
BABA   92.30 (-1.99%)
AMD   69.46 (-1.43%)
T   19.17 (+0.26%)
MU   55.46 (+0.47%)
CGC   2.93 (-5.18%)
F   13.21 (+0.69%)
GE   82.08 (-1.85%)
DIS   93.90 (+1.46%)
AMC   5.85 (-3.62%)
PYPL   74.16 (-0.08%)
PFE   51.84 (+0.12%)
NFLX   323.54 (+4.28%)
S&P 500   3,959.56 (-0.10%)
DOW   33,683.61 (-0.29%)
QQQ   283.68 (-0.06%)
AAPL   143.94 (+0.90%)
MSFT   246.44 (-0.39%)
META   116.46 (+0.98%)
GOOGL   93.29 (-0.45%)
AMZN   89.57 (-0.86%)
TSLA   180.30 (+3.96%)
NVDA   172.75 (+0.62%)
NIO   12.81 (-4.47%)
BABA   92.30 (-1.99%)
AMD   69.46 (-1.43%)
T   19.17 (+0.26%)
MU   55.46 (+0.47%)
CGC   2.93 (-5.18%)
F   13.21 (+0.69%)
GE   82.08 (-1.85%)
DIS   93.90 (+1.46%)
AMC   5.85 (-3.62%)
PYPL   74.16 (-0.08%)
PFE   51.84 (+0.12%)
NFLX   323.54 (+4.28%)
S&P 500   3,959.56 (-0.10%)
DOW   33,683.61 (-0.29%)
QQQ   283.68 (-0.06%)
AAPL   143.94 (+0.90%)
MSFT   246.44 (-0.39%)
META   116.46 (+0.98%)
GOOGL   93.29 (-0.45%)
AMZN   89.57 (-0.86%)
TSLA   180.30 (+3.96%)
NVDA   172.75 (+0.62%)
NIO   12.81 (-4.47%)
BABA   92.30 (-1.99%)
AMD   69.46 (-1.43%)
T   19.17 (+0.26%)
MU   55.46 (+0.47%)
CGC   2.93 (-5.18%)
F   13.21 (+0.69%)
GE   82.08 (-1.85%)
DIS   93.90 (+1.46%)
AMC   5.85 (-3.62%)
PYPL   74.16 (-0.08%)
PFE   51.84 (+0.12%)
NFLX   323.54 (+4.28%)
S&P 500   3,959.56 (-0.10%)
DOW   33,683.61 (-0.29%)
QQQ   283.68 (-0.06%)
AAPL   143.94 (+0.90%)
MSFT   246.44 (-0.39%)
META   116.46 (+0.98%)
GOOGL   93.29 (-0.45%)
AMZN   89.57 (-0.86%)
TSLA   180.30 (+3.96%)
NVDA   172.75 (+0.62%)
NIO   12.81 (-4.47%)
BABA   92.30 (-1.99%)
AMD   69.46 (-1.43%)
T   19.17 (+0.26%)
MU   55.46 (+0.47%)
CGC   2.93 (-5.18%)
F   13.21 (+0.69%)
GE   82.08 (-1.85%)
DIS   93.90 (+1.46%)
AMC   5.85 (-3.62%)
PYPL   74.16 (-0.08%)
PFE   51.84 (+0.12%)
NFLX   323.54 (+4.28%)
NASDAQ:PRFX

PainReform - PRFX Stock Forecast, Price & News

$0.50
+0.11 (+29.49%)
(As of 12/9/2022 01:31 PM ET)
Add
Compare
Today's Range
$0.44
$0.55
50-Day Range
$0.38
$0.69
52-Week Range
$0.34
$1.79
Volume
801 shs
Average Volume
15,158 shs
Market Capitalization
$5.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PRFX stock logo

About PainReform (NASDAQ:PRFX) Stock

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

Receive PRFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PainReform and its competitors with MarketBeat's FREE daily newsletter.

PRFX Stock News Headlines

PainReform Provides PRF-110 Manufacturing Update
PainReform Ltd. (PRFX)
See More Headlines
Receive PRFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PainReform and its competitors with MarketBeat's FREE daily newsletter.

PRFX Company Calendar

Last Earnings
11/15/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/15/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRFX
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.73 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.32 million
Optionable
Not Optionable
Beta
-0.34

Key Executives

  • Dr. Ehud Geller Ph.D.
    Exec. Chairman
  • Mr. Ilan Hadar M.B.A. (Age 53)
    MBA, CEO & CFO
  • Dr. Sigal Aviel (Age 58)
    Chief Operating Officer
  • Prof. Eli Hazum Ph.D.
    CTO & Director
  • Dr. Stephen A. Cooper D.M.D Ph.D.
    Exec. VP of Devel.













PRFX Stock - Frequently Asked Questions

How have PRFX shares performed in 2022?

PainReform's stock was trading at $1.33 on January 1st, 2022. Since then, PRFX shares have decreased by 71.0% and is now trading at $0.3862.
View the best growth stocks for 2022 here
.

Are investors shorting PainReform?

PainReform saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 400 shares, a drop of 87.9% from the October 31st total of 3,300 shares. Based on an average daily volume of 8,200 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.
View PainReform's Short Interest
.

When is PainReform's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 15th 2023.
View our PRFX earnings forecast
.

How were PainReform's earnings last quarter?

PainReform Ltd. (NASDAQ:PRFX) issued its quarterly earnings data on Monday, November, 15th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.43) by $0.25.

What other stocks do shareholders of PainReform own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PainReform investors own include Novartis (NVS), AbbVie (ABBV), American Airlines Group (AAL), Bank of America (BAC), Bristol-Myers Squibb (BMY), Clorox (CLX), Cisco Systems (CSCO), CVS Health (CVS), Delta Air Lines (DAL) and DocuSign (DOCU).

When did PainReform IPO?

(PRFX) raised $20 million in an initial public offering (IPO) on Tuesday, September 1st 2020. The company issued 2,500,000 shares at a price of $8.00 per share. Maxim Group and Joseph Gunnar acted as the underwriters for the IPO.

What is PainReform's stock symbol?

PainReform trades on the NASDAQ under the ticker symbol "PRFX."

How do I buy shares of PainReform?

Shares of PRFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PainReform's stock price today?

One share of PRFX stock can currently be purchased for approximately $0.39.

How much money does PainReform make?

PainReform (NASDAQ:PRFX) has a market capitalization of $4.11 million.

How can I contact PainReform?

The official website for the company is www.painreform.com. The company can be reached via phone at 972-9960-1901 or via email at prfx@crescendo-ir.com.

This page (NASDAQ:PRFX) was last updated on 12/9/2022 by MarketBeat.com Staff